Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaw Chyn Lim

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Plos One|August 29, 2012
Gelsolin induces colorectal tumor cell invasion via modulation of the urokinase-type plasminogen activator cascadeJingli Zhuo, Ee Hong Tan, Benedict Yan, et al.
Hepatology (Baltimore, Md.)|November 4, 2014
CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinomaGuo-Dong Lu, Yang Huey Ang, Jing Zhou, et al.
International Journal of Oncology|September 3, 2010
Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cellsPuei Nam Tay, Patrick Tan, Yuhong Lan, et al.
Theranostics|October 21, 2024
Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistanceJayshree Hirpara, Win Lwin Thuya, Sok-Hwee Cheow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomasJia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
NPJ Precision Oncology|April 16, 2026
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancersJie Qing Eu, Nur Afiqah Binte Mohamed Salleh, Jayshree Hirpara, et al.
The Journal of Clinical Investigation|September 26, 2023
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignanciesStephen Jun Fei Chong, Fen Zhu, Olga Dashevsky, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
The Lancet. Oncology|January 18, 2025
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trialWan-Qin Chong, Jia-Li Low, Joshua K Tay, et al.
Theranostics|January 12, 2023
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesWin Lwin Thuya, Li Ren Kong, Nicholas L Syn, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Plos One|August 29, 2012
Gelsolin induces colorectal tumor cell invasion via modulation of the urokinase-type plasminogen activator cascadeJingli Zhuo, Ee Hong Tan, Benedict Yan, et al.
Hepatology (Baltimore, Md.)|November 4, 2014
CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinomaGuo-Dong Lu, Yang Huey Ang, Jing Zhou, et al.
International Journal of Oncology|September 3, 2010
Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cellsPuei Nam Tay, Patrick Tan, Yuhong Lan, et al.
Theranostics|October 21, 2024
Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistanceJayshree Hirpara, Win Lwin Thuya, Sok-Hwee Cheow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomasJia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
NPJ Precision Oncology|April 16, 2026
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancersJie Qing Eu, Nur Afiqah Binte Mohamed Salleh, Jayshree Hirpara, et al.
The Journal of Clinical Investigation|September 26, 2023
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignanciesStephen Jun Fei Chong, Fen Zhu, Olga Dashevsky, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
The Lancet. Oncology|January 18, 2025
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trialWan-Qin Chong, Jia-Li Low, Joshua K Tay, et al.
Theranostics|January 12, 2023
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesWin Lwin Thuya, Li Ren Kong, Nicholas L Syn, et al.
Pageof 4